[ad_1] Early-stage Phase 1 and 2 human trials are likely to be concluded in the next three months Zydus Cadila plans to complete late-stage trials for its novel coronavirus vaccine candidate by February or March and could produce up to 100 million doses a year initially if it is successful, the company chairman said Friday. […]
Continue Reading
[ad_1] China isn’t seeking to confront or replace the United States as the world’s top technological power, but will fight back against “malicious slander” and attacks from Washington, a foreign ministry spokesperson said Friday, responding to a litany of recent accusations from the Trump administration. Hua Chunying said China’s chief concern was improving the livelihoods […]
Continue Reading
[ad_1] Politicians and public health leaders have publicly committed to equitably sharing any coronavirus vaccine that works, but the top global initiative to make that happen may allow rich countries to reinforce their own stockpiles while making fewer doses available for poor ones. Activists warn that without stronger attempts to hold political, pharmaceutical and health […]
Continue Reading
[ad_1] A Russian university has claimed the clinical trials of the world’s first vaccine against the coronavirus disease (Covid-19) on volunteers have been completed successfully. The Sechenov First Moscow State Medical University began clinical trials of the vaccine against Sars-Cov-2, which causes the coronavirus disease, was produced by Russia’s Gamaleya Institute of Epidemiology and Microbiology […]
Continue Reading
[ad_1] COVAXIN, India’s first COVID-19 vaccine candidate, was developed in association with ICMR New Delhi: Approval for human clinical trials for two made-in-India COVID-19 vaccine candidates – COVAXIN and ZyCov-D – marks the “beginning of the end” for the novel coronavirus pandemic that has infected over 1.12 crore people worldwide and left more than 5.3 […]
Continue Reading
[ad_1] The ICMR talked about plans to launch the vaccine for public health use by August 15. Highlights Covaxin will be first made-in-India coronavirus vaccine The virus has infected over 10 million and killed 500,000 people globally No vaccine has yet been approved for commercial use against COVID-19 New Delhi: The first made-in-India coronavirus vaccine […]
Continue Reading
[ad_1] The vaccine will be produced by Brazil’s Fundacao Osvaldo Cruz (Representational) Sao Paolo: Brazil announced on Saturday that it had signed a $127 million agreement to start producing locally an experimental vaccine developed by AstraZeneca that has shown promise to fight the COVID-19 pandemic. The AstraZeneca vaccine is considered the world’s leading candidate and […]
Continue Reading
[ad_1] WHO is in talks with multiple Chinese manufacturers for potential coronavirus vaccines (File) Geneva: AstraZeneca’s experimental COVID-19 vaccine is probably the world’s leading candidate and most advanced in terms of development, the World Health Organization’s (WHO) chief scientist said on Friday. The British drugmaker has already begun large-scale, mid-stage human trials of the vaccine, […]
Continue Reading
[ad_1] AstraZeneca’s experimental Covid-19 vaccine is probably the world’s leading candidate and most advanced in terms of development, the World Health Organization’s (WHO) chief scientist said on Friday. The British drugmaker has already begun large-scale, mid-stage human trials of the vaccine, which was developed by researchers at University of Oxford. This week, AstraZeneca signed its […]
Continue Reading
[ad_1] It is not certain that scientists will be able to create an effective vaccine against the coronavirus that has caused the Covid-19 pandemic, but it could take a year before one were to be invented, the head of the World Health Organisation said. Speaking by video-conference to deputies from the European Parliament’s health committee, […]
Continue Reading